Antihypoglycemic Agent class drugs

2 results
  • gvoke hypopen

    (glucagon injection, solution)
    Xeris Pharmaceuticals, Inc.
    GVOKE is indicated for the subcutaneous treatment of severe hypoglycemia in adults and pediatric patients (aged 2 and older) with diabetes. Additionally, GVOKE VialDx is used intravenously as a diagnostic aid to temporarily inhibit gastrointestinal movement during radiologic examinations in adults.